Efficacy of CAD in Screening Colonoscopy to Reduce the Risk of Advanced Adenoma at 3 Years.
Sponsor: University Hospital, Bordeaux • ClinicalTrials.gov ID: NCT07299071
Recruiting for Similar Conditions?
Sponsors are looking for patients like you. See if you qualify for compensated research studies.
Check Eligibility →Description
The occurrence of interval cancers after colonoscopy raises the possibility of missed lesions. High- performance computer aided diagnosis (CAD) systems have been specially designed for the detection of colorectal lesions (CAD for detection is named CADe). The use of CADe improves adenoma detection in screening colonoscopy. The potential of CADe system in reducing the rate of progression to advanced polyps or interval cancer between two colonoscopies remains still uncertain.
Interventions
-
Standard colonoscopy
(Procedure)
Colonoscopy standard (without CADe)
-
Colonoscopy CADe
(Procedure)
colonoscopy with CADe
Eligibility criteria
Conditions
Locations
- CH de la Côte Basque — Bayonne, France
- CHU Brest la Cavale Blanche — Brest, France
- Hôpital de Carhaix — Carhaix-Plouguer, France
- Clinique Paris Bercy — Charenton-le-Pont, France
- CHU de Limoges — Limoges, France
- Institut Paoli Calmettes — Marseille, France
- Clinique Jules Verne — Nantes, France
- CHU Nîmes — Nîmes, France
- APHP - Hôpital Saint Antoine — Paris, France
- Aphp-Hegp — Paris, France
- APHP - Hôpital Tenon — Paris, France
- CHU Bordeaux - Hôpital Haut Lévêque — Pessac, France
- CHU de Rennes — Rennes, France
- Clinique Pasteur — Toulouse, France
- CHRU de Nancy - Hôpital Brabois Adultes — Vandœuvre-lès-Nancy, France
Partner with Nurenyx
Showcase your study to thousands of motivated patients matching your criteria.
Learn MoreOfficial Source
Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
View Official Record